Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 2 months ago

Possible Interaction: Secretin and Somatostatin

supplement:

Secretin

Research Papers that Mention the Interaction

Secretin inhibited acid secretion by 54% (p less than 0.05), and somatostatin inhibited by 70% (p less than 0.05).
The combined infusion of secretin and somatostatin decreased acid output by 64% (p less than 0.05).
The inhibitory effect of intravenous infusion of secretin (0.05 CU kg-1h-1) and somatostatin (60 pmol kg-1h-1), given alone or in combination, on pentagastrin-stimulated (100 ng kg-1 h-1) acid secretion was studied in 10 healthy subjects.
Scandinavian journal of gastroenterology  •  1989  |  View Paper
The pattern of inhibition of amylase and chymotrypsin secretion is different and difficult to interpret from the present study, but somatostatin may inhibit also the secretin stimulated pancreatic secretion of enzymes completely, as the inhibitory effect seemed to decline when larger doses of secretin were applied.
The pattern of inhibition suggests that somatostatin is a competitive inhibitor of secretin in the stimulation of pancreatic secretion of bicarbonate, which supports the hypothesis of a direct effect of somatostatin on the exocrine secretory cells of the pancreas.
The secretion of bicarbonate, amylase, and chymotrypsin in response to secretin was significantly reduced by somatostatin.
Journal of endocrinological investigation  •  1980  |  View Paper
Somatostatin is a hypothalamic peptide hormone that inhibits the secretion of growth hormone, glucagon, insulin, gastrin and secretin , and also plays a role in neural transmission.
The journal of peptide research : official journal of the American Peptide Society  •  2001  |  View Paper
Somatostatin probably inhibits pancreatic exocrine secretion by a variety of mechanisms which depend on … the type of secretion studied (postprandial vs. interdigestive secretion, protein vs. bicarbonate secretion): Somatostatin may act via inhibition of the … hormones such as cholecystokinin (CCK) and secretin or via intrapancreatic inhibition … or action of CCK.
Digestion  •  1994  |  View Paper
In addition to its well-known growth hormone inhibition properties, somatostatin inhibits the release or action of thyrotropin, insulin, glucagon, secretin , gastrin, cholecystokinin, gastric inhibitory polypeptide (GIP), pancreatic polypeptide, neurotensin, and motilin.
Annals of the New York Academy of Sciences  •  1988  |  View Paper
To minimize any possible error in the estimation of insulin removal as a result of endogenous insulin, pancreatic insulin secretion was suppressed by intravenous administration of somatostatin (500 micrograms/h).
Metabolism: clinical and experimental  •  1984  |  View Paper
Since secretin and somatostatin differ in their respective effects on gastrointestinal blood flow it is suggested that the previously reported beneficial effects of both peptides on upper gastrointestinal bleeding cannot solely be attributed to changes in regional blood flow.
Regulatory Peptides  •  1982  |  View Paper
Secretin at a concentration of 0.3 U/ml and gastric inhibitory polypeptide concentration of 58 ng/ml produced a prompt twoto threefold rise in mean somatostatin release, which persisted throughout the perfusion period.
Diabetes  •  1978  |  View Paper
A few cases have been reported in the literature, complete shrinkage of a pituitary GH secreting macroadenoma after long-term somatostatin analogue administration.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association  •  2009  |  View Paper
Therapy with somatostatin analogues (SSAs) induce control of GH and IGF-I excess in the majority of patients, but their inhibitory effect on pancreatic insulin secretion might complicate the overall effect of this treatment on glucose tolerance.
Acta Diabetologica  •  2009  |  View Paper
Show More